HELLO WORLD

HOCl is the Next Generation Irrigation Solution for Complex Wounds，Explore the new alternative in wound management—hypochlorous acid (HOCl).

Sterile Saline vs. HOCl

In a 2022 published study, suction-blister models were used to raise and de-roof the skin in 20 healthy volunteers, individuals were randomly assigned a stabilized hypochlorous acid solution or sterile saline solution and the wounds were irrigated and treated on day 0, 2, and 4. Researchers found that the hypochlorous acid solution increased re-epithelialization on day 4 by 14% compared with the control solution (95% confidence interval (CI) 6.8–20%, p = 0.00051) and was not inferior (p < 0.0001) to the control solution on day 10 (0.3%, 95% CI –1.3–1.9%). Additionally, researchers found median bacterial counts were lower with stabilized hypochlorous acid compared with control and were further reduced after irrigation and treatment of both groups on day 4, but remained lower in the stabilized hypochlorous acid group compared with the control group. Researchers concluded that while both solutions initially reduced the bacterial count present in the wounds, by the time of definitive closure, the saline-irrigated wounds had bacterial counts back up to 10 whereas the HOCl–irrigated wounds remained at 10 or lower. Upwards of 80% of the patients in the saline group had postoperative closure.

Povidone Iodine vs. HOCl

With both anti-microbial properties and anti-inflammatory properties, hypochlorous acid presents an efficacious, multi-beneficial solution for both mechanical irrigation and debridement in wound management and surgical irrigation. In a 2020 publishing, researchers used hypochlorous-acid to irrigate a horseshoe perianal abscess in an immunocompromised patient when a povidone iodine solution was deemed ineffective and painful for the patient⁵. The patient reported little discomfort with the initial HOCl-irrigation, and the day following the irrigation procedure the patient’s fever was noticeably reduced⁵. Researchers noted the patient’s infection cleared within 2 weeks, and a subsequent swab culture found no microbial growth present in the healed cavity⁵. In fact, the wound volume was reduced by more than 90% after 5 weeks, and final wound closure was achieved after 6 weeks⁵. In contrast to this case, the study notes another patient with a horseshoe perianal abscess who received traditional irrigation with a diluted povidone iodine and wet-to-dry dressing faced similar problems, but the fever in this case did not subside, and the wound became even more complicated.

FDA 510(k) Cleared，Over-the-Counter (OTC) Production: Fully compliant with healthcare manufacturing standards.

Expanding Production for Advanced Wound Care Solutions

Wufland is actively expanding its FDA-registered OTC production capabilities to meet the growing demand for advanced wound care solutions in hospitals and healthcare facilities. Leveraging cutting-edge manufacturing technology, we provide scalable production and precision bottling for hypochlorous acid (HOCl) wound irrigation products. Our end-to-end solutions ensure compliance with global healthcare standards and enable hospitals to adopt next-generation, effective wound management solutions. Wufland is committed to delivering safe, effective, and innovative products that support improved patient care and faster healing.

Medical-Grade Bottle

Wufland Medical-grade bottles designed to meet the highest safety and quality standards for medical and clinical use. Our bottles are tailored for wound care and irrigation products, ensuring durability, chemical compatibility, and optimal product preservation.

Springless Pump technology

Our springless pump technology offers a contamination-free dispensing solution ideal for medical applications. Designed for consistent and hygienic liquid delivery, it minimizes clogging and ensures precise dosage without metal spring components.

Label design and Printing

Wufland delivers customized, regulation-compliant labels with high-quality printing. Our design services align with FDA, EPA, and global standards, ensuring clear, durable, and professional labeling for medical products.

PRODUCTION

Wufland Production Capacity & Supply Chain Efficiency

Wufland leverages cutting-edge manufacturing and supply chain innovations to deliver scalable, high-volume production with speed and precision. Our FDA-registered facilities ensure consistent quality, regulatory compliance, and operational flexibility. Backed by the WSCF Supply Chain Platform, we provide seamless integration from raw material sourcing to distribution, empowering brands to scale efficiently and meet market demands. Our agile production and logistics capabilities guarantee timely delivery, cost savings, and sustainable growth for medical and clinical care products.

20,000

Daily Production Capacity: Up to 20,000 units/day, ensuring high-volume, consistent output for medical and clinical care products.

20%

Rapid Delivery Cycles:20–30% shorter lead times through on-demand production and optimized logistics, enabling faster market responsiveness.

3,000

Minimum Orders: Flexible, scalable production lines meet diverse product needs with full regulatory compliance—minimum orders as low as 3,000 units/SKU.